A multicentre trial to evaluate the efficacy and safety of tocilizumab versus anakinra in patients with adult-onset Still's disease.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2016
At a glance
- Drugs Anakinra (Primary) ; Tocilizumab (Primary)
- Indications Adult-onset Still's disease
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2016 New trial record